{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:58:52Z","timestamp":1790355532115,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003806","name":"Hokuto Foundation for Bioscience","doi-asserted-by":"publisher","award":["none"],"award-info":[{"award-number":["none"]}],"id":[{"id":"10.13039\/501100003806","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Leucine-rich repeat-containing G-protein-coupled receptor 5 (LGR5) is a promising intestinal stem cell and carcinoma stem cell marker. We examined the relationship between mismatch repair (MMR) protein deficiency and\n                      <jats:italic>LGR5<\/jats:italic>\n                      expression in poorly differentiated (PD) colorectal carcinoma (CRC).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In 29 cases of PD-CRC, deficiencies in MMR proteins (MLH1, PMS2, MSH2, MSH6) and \u03b2-catenin expression were identified by immunohistochemistry (IHC).\n                      <jats:italic>LGR5<\/jats:italic>\n                      expression was examined by the RNAscope assay in tissue microarrays.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>LGR5<\/jats:italic>\n                      H-scores in MMR-deficient (MMR-D) cases were significantly lower than those in MMR-proficient (MMR-P) cases (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0033). Nuclear \u03b2-catenin IHC scores in MMR-D cases were significantly lower than those in MMR-P cases (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0024). In all cases, there was a positive correlation between\n                      <jats:italic>LGR5<\/jats:italic>\n                      H-score and nuclear \u03b2-catenin IHC score (r\u2009=\u20090.6796,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Even in MMR-D and MMR-P cases, there was a positive correlation between\n                      <jats:italic>LGR5<\/jats:italic>\n                      H-score and nuclear \u03b2-catenin IHC score (r\u2009=\u20090.7180,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0085 and r\u2009=\u20090.6574,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.003, respectively). MMR-D CRC cases showed low expression of\n                      <jats:italic>LGR5<\/jats:italic>\n                      , which may be due to low activation of the Wnt\/\u03b2-catenin signaling pathway.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our results reveal the relationship between\n                      <jats:italic>LGR5<\/jats:italic>\n                      expression and MMR protein profiles in PD-CRC. A further study is warranted to confirm these findings.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-06791-8","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T09:03:53Z","timestamp":1586941433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Characterization of LGR5 expression in poorly differentiated colorectal carcinoma with mismatch repair protein deficiency"],"prefix":"10.1186","volume":"20","author":[{"given":"Tomoyuki","family":"Nakajima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Iwaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyoshi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,15]]},"reference":[{"key":"6791_CR1","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1053\/j.gastro.2010.03.002","volume":"138","author":"N Barker","year":"2010","unstructured":"Barker N, Clevers H. Leucine-rich repeat-containing G-protein-coupled receptors as markers of adult stem cells. Gastroenterology. 2010;138:1681\u201396.","journal-title":"Gastroenterology."},{"key":"6791_CR2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nature21713","volume":"543","author":"F de Sousa e Melo","year":"2017","unstructured":"de Sousa e Melo F, Kurtova AV, Harnoss JM, Kljavin N, Hoeck JD, Hung J, et al. A distinct role for Lgr5(+) stem cells in primary and metastatic colon cancer. Nature. 2017;543:676\u201380.","journal-title":"Nature"},{"key":"6791_CR3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1477-7819-10-244","volume":"10","author":"XS Wu","year":"2012","unstructured":"Wu XS, Xi HQ, Chen L. Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival. World J Surg Oncol. 2012;10:244.","journal-title":"World J Surg Oncol"},{"key":"6791_CR4","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/j.ajpath.2018.06.012","volume":"188","author":"BG Jang","year":"2018","unstructured":"Jang BG, Kim HS, Chang WY, Bae JM, Kim WH, Kang GH. Expression profile of LGR5 and its prognostic significance in colorectal Cancer progression. Am J Pathol. 2018;188:2236\u201350.","journal-title":"Am J Pathol"},{"key":"6791_CR5","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.3748\/wjg.v23.i20.3632","volume":"23","author":"M Navarro","year":"2017","unstructured":"Navarro M, Nicolas A, Ferrandez A, Lanas A. Colorectal cancer population screening programs worldwide in 2016: an update. World J Gastroenterol. 2017;23:3632\u201342.","journal-title":"World J Gastroenterol"},{"key":"6791_CR6","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","volume":"61","author":"ER Fearon","year":"1990","unstructured":"Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759\u201367.","journal-title":"Cell."},{"key":"6791_CR7","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1053\/j.gastro.2009.12.066","volume":"138","author":"B Leggett","year":"2010","unstructured":"Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology. 2010;138:2088\u2013100.","journal-title":"Gastroenterology."},{"key":"6791_CR8","doi-asserted-by":"crossref","first-page":"46468","DOI":"10.18632\/oncotarget.17576","volume":"8","author":"TJ Liang","year":"2017","unstructured":"Liang TJ, Wang HX, Zheng YY, Cao YQ, Wu X, Zhou X, et al. APC hypermethylation for early diagnosis of colorectal cancer: a meta-analysis and literature review. Oncotarget. 2017;8:46468\u201379.","journal-title":"Oncotarget."},{"key":"6791_CR9","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1056\/NEJM199805213382101","volume":"338","author":"LA Aaltonen","year":"1998","unstructured":"Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med. 1998;338:1481\u20137.","journal-title":"N Engl J Med"},{"key":"6791_CR10","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.1158\/1078-0432.CCR-10-0821","volume":"16","author":"SA Martin","year":"2010","unstructured":"Martin SA, Lord CJ. Ashworth a therapeutic targeting of the DNA mismatch repair pathway. Clin Cancer Res. 2010;16:5107\u201313.","journal-title":"Clin Cancer Res"},{"key":"6791_CR11","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1200\/JCO.2009.27.0652","volume":"28","author":"A de la Chapelle","year":"2010","unstructured":"de la Chapelle A, Hampel H. Clinical relevance of microsatellite instability in colorectal cancer. J Clin Oncol. 2010;28:3380\u20137.","journal-title":"J Clin Oncol"},{"key":"6791_CR12","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1136\/jcp.41.5.532","volume":"41","author":"TB Halvorsen","year":"1988","unstructured":"Halvorsen TB, Seim E. Degree of differentiation in colorectal adenocarcinomas: a multivariate analysis of the influence on survival. J Clin Pathol. 1988;41:532\u20137.","journal-title":"J Clin Pathol"},{"key":"6791_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/jnci\/djk051","volume":"99","author":"K Lagerstedt Robinson","year":"2007","unstructured":"Lagerstedt Robinson K, Liu T, Vandrovcova J, Halvarsson B, Clendenning M, Frebourg T, et al. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J Natl Cancer Inst. 2007;99:291\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"6791_CR14","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1097\/PAS.0b013e31829ab1c1","volume":"37","author":"JH Kim","year":"2013","unstructured":"Kim JH, Rhee YY, Bae JM, Cho NY, Kang GH. Loss of CDX2\/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer. Am J Surg Pathol. 2013;37:1532\u201341.","journal-title":"Am J Surg Pathol"},{"key":"6791_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/mp.56.6.347","volume":"56","author":"SC Wong","year":"2003","unstructured":"Wong SC, Lo ES, Chan AK, Lee KC, Hsiao WL. Nuclear beta catenin as a potential prognostic and diagnostic marker in patients with colorectal cancer from Hong Kong. Mol Pathol. 2003;56:347\u201352.","journal-title":"Mol Pathol"},{"key":"6791_CR16","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1097\/PAS.0b013e318220e59d","volume":"35","author":"OC Ukpo","year":"2011","unstructured":"Ukpo OC, Flanagan JJ, Ma XJ, Luo Y, Thorstad WL, Lewis JS Jr. High-risk human papillomavirus E6\/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol. 2011;35:1343\u201350.","journal-title":"Am J Surg Pathol"},{"key":"6791_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00384-010-0903-z","volume":"25","author":"XS Fan","year":"2010","unstructured":"Fan XS, Wu HY, Yu HP, Zhou Q, Zhang YF, Huang Q. Expression of Lgr5 in human colorectal carcinogenesis and its potential correlation with beta-catenin. Int J Color Dis. 2010;25:583\u201390.","journal-title":"Int J Color Dis"},{"key":"6791_CR18","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers H, Nusse R. Wnt\/beta-catenin signaling and disease. Cell. 2012;149:1192\u2013205.","journal-title":"Cell."},{"key":"6791_CR19","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science. 2013;339:1546\u201358.","journal-title":"Science."},{"key":"6791_CR20","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1053\/j.gastro.2006.08.039","volume":"132","author":"LG Van der Flier","year":"2007","unstructured":"Van der Flier LG, Sabates-Bellver J, Oving I, Haegebarth A, De Palo M, Anti M, et al. The Intestinal Wnt\/TCF Signature. Gastroenterology. 2007;132:628\u201332.","journal-title":"Gastroenterology"},{"key":"6791_CR21","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1002\/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.0.CO;2-U","volume":"91","author":"TC Smyrk","year":"2001","unstructured":"Smyrk TC, Watson P, Kaul K, Lynch HT. Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer. 2001;91:2417\u201322.","journal-title":"Cancer."},{"key":"6791_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1136\/gut.2008.155473","volume":"58","author":"S Ogino","year":"2009","unstructured":"Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Meyerhardt JA, Loda M, et al. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut. 2009;58:90\u20136.","journal-title":"Gut."},{"key":"6791_CR23","doi-asserted-by":"publisher","first-page":"8654","DOI":"10.1038\/srep08654","volume":"5","author":"AM Baker","year":"2015","unstructured":"Baker AM, Graham TA, Elia G, Wright NA, Rodriguez-Justo M. Characterization of LGR5 stem cells in colorectal adenomas and carcinomas. Sci Rep. 2015;5:8654.","journal-title":"Sci Rep"},{"key":"6791_CR24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/his.12787","volume":"68","author":"BG Jang","year":"2016","unstructured":"Jang BG, Kim HS, Kim KJ, Rhee YY, Kim WH, Kang GH. Distribution of intestinal stem cell markers in colorectal precancerous lesions. Histopathology. 2016;68:567\u201377.","journal-title":"Histopathology."},{"key":"6791_CR25","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41416-018-0118-6","volume":"118","author":"RG Morgan","year":"2018","unstructured":"Morgan RG, Mortensson E, Williams AC. Targeting LGR5 in colorectal Cancer: therapeutic gold or too plastic? Br J Cancer. 2018;118:1410\u20138.","journal-title":"Br J Cancer"},{"key":"6791_CR26","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015;372:2509\u201320.","journal-title":"N Engl J Med"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-06791-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-06791-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-06791-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T19:43:26Z","timestamp":1618429406000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-06791-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,15]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6791"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-06791-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.23931\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.23931\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,15]]},"assertion":[{"value":"6 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Shinshu University School of Medicine (Approval Code: 4088). The requirement of informed consent was waived and an opt-out method was used due to the retrospective design of the study. The investigation was conducted in compliance with the Helsinki Declaration.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"319"}}